Quantum Biopharma (QNTM) Current Leases (2019 - 2026)
Quantum Biopharma recorded quarterly Current Leases of $83991.0 in Q1 2026, down 18.59% quarter-over-quarter from $103165.0 in Q4 2025, and up 137.54% year-over-year from $35358.0 in Q1 2025.
Quantum Biopharma's Current Leases history runs 8 years deep, the most recent figure standing at $83991.0 for Q1 2026.
- In Q1 2026, Current Leases rose 137.54% year-over-year to $83991.0; the TTM figure through Mar 2026 stood at $83991.0 (up 137.54% YoY), while the FY2025 annual figure was $103165.0, up 91.83% from the prior year.
- Current Leases came in at $83991.0 for Q1 2026 at Quantum Biopharma, down from $103165.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $198273.0 in Q3 2022 to a low of $9634.0 in Q2 2024.
- A 5-year average of $111533.3 and a median of $107202.0 in 2023 frame the typical range for Current Leases.
- Across the five-year window, Current Leases plunged 91.01% in 2024 and jumped 1525.2% in 2025, its largest moves.
- Quantum Biopharma's Current Leases stood at $177870.0 in 2022, then sank by 64.97% to $62308.0 in 2023, then declined by 13.69% to $53780.0 in 2024, then jumped by 91.83% to $103165.0 in 2025, then fell by 18.59% to $83991.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $83991.0, $103165.0, and $151798.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 16.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83,991.00 |
| Dec 31, 2025 | 103,165.00 |
| Sep 30, 2025 | 151,798.00 |
| Jun 30, 2025 | 156,572.00 |
| Mar 31, 2025 | 35,358.00 |
| Dec 31, 2024 | 53,780.00 |
| Sep 30, 2024 | 72,475.00 |
| Jun 30, 2024 | 9,634.00 |
| Sep 30, 2023 | 62,308.00 |
| Jun 30, 2023 | 107,202.00 |
| Mar 31, 2023 | 141,702.00 |
| Dec 31, 2022 | 177,870.00 |
| Sep 30, 2022 | 198,273.00 |
| Jun 30, 2022 | 158,976.00 |
| Mar 31, 2022 | 159,895.00 |
| Dec 31, 2021 | 124,311.00 |
| Sep 30, 2021 | 50,126.00 |
| Jun 30, 2021 | 61,626.00 |
| Mar 31, 2021 | 70,513.00 |
| Dec 31, 2020 | 46,842.00 |
| Sep 30, 2020 | 84,493.95 |
| Jun 30, 2020 | 89,611.03 |
| Mar 31, 2020 | 101,225.35 |
| Dec 31, 2019 | 111,096.22 |